This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Liverpool. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Michael Day - Innovator in Retinal Treatment
Introduction
Michael Day is a notable inventor based in Wirral, GB. He has made significant contributions to the field of medical treatments, particularly in the area of ophthalmology. His innovative work focuses on developing solutions for retinal issues, showcasing his dedication to improving patient outcomes.
Latest Patents
Michael Day holds a patent for a composition aimed at treating a detached retina. The patent, titled "Composition for treatment of a detached retina and method of production thereof," describes a unique formulation that includes an oil and an additive designed to enhance the extensional viscosity of the oil. This invention not only addresses a critical medical need but also provides a method and kit for producing the composition, demonstrating his commitment to practical applications of his research.
Career Highlights
Michael Day is affiliated with the University of Liverpool, where he contributes to research and development in medical treatments. His work has garnered attention for its potential impact on the treatment of retinal detachment, a condition that can lead to severe vision loss if not addressed promptly. His innovative approach reflects a blend of scientific rigor and practical application.
Collaborations
Michael Day has collaborated with esteemed colleagues, including Michael J Garvey and Rachel Lucinda Williams. These partnerships highlight the collaborative nature of research and innovation in the medical field, as they work together to advance knowledge and develop effective treatments.
Conclusion
Michael Day's contributions to the field of retinal treatment exemplify the importance of innovation in medicine. His patent and ongoing research efforts reflect a commitment to improving healthcare outcomes for patients suffering from retinal conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
